Evaluation of Medication Nonadherence in Sickle Cell Disease Post Hematopoietic Stem Cell Transplantation
Date Issued
May 2026
Author(s)
Evans, Misty D
The University of Tennessee
Advisor(s)
Lisa Lindley
Additional Advisor(s)
Samereh Abdoli
Dominique Bulgin
Micah Skeens
Abstract
Sickle cell disease (SCD) is a common inherited blood disorder caused by the polymerization of hemoglobin S, leading to stiff, sickle-shaped red blood cells. The distorted red blood cells obstruct blood vessels and compromise circulation. Insufficient blood flow to tissue results in severe pain and, over time, multi-organ damage. With the emergence of haploidentical transplantation, children with SCD are increasingly pursuing hematopoietic stem cell transplantation (HSCT) as a curative treatment approach. However, suboptimal medication adherence is a significant issue in both SCD and HSCT populations. Adherence to complex medication regimens is crucial to reducing the risk of severe complications and early mortality following transplantation. This dissertation, presented in manuscript format, explores medication adherence rates and associated health outcomes in children with sickle cell disease post-HSCT. Chapter 1 identifies the problem, highlighting the gap in the literature regarding medication adherence among children with SCD undergoing HSCT. Chapter 2 presents an integrative review of the literature, revealing both the limited research on medication adherence in pediatric SCD and HSCT and the lack of studies on health outcomes related to medication nonadherence. Chapter 3 provides an analysis of the Self-Regulation Theory and introduces a revised framework for evaluating medication adherence in SCD. In Chapter 4, a secondary analysis of sirolimus drug assay levels among children with SCD post-HSCT was conducted to assess adherence rates. The relationship between nonadherence and transplant outcomes, including graft-versus-host disease and hospital readmission, was evaluated and reported. Key findings were reviewed, and suggestions for future nursing research, practice, and policy were provided.
Degree
Doctor of Philosophy
Major
Nursing
Embargo Date
May 1, 2029